Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116429992 | 11642999 | 2 | F | 20150509 | 20160801 | 20151020 | 20160803 | EXP | US-ROCHE-1646402 | ROCHE | 53.17 | YR | M | Y | 81.00000 | KG | 20160803 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116429992 | 11642999 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 50722 | 600 | MG | BID | ||||||||
116429992 | 11642999 | 2 | SS | ASKP1240 | BLESELUMAB | 1 | Intravenous (not otherwise specified) | Y | 0 | 200 | MG | /month | |||||||
116429992 | 11642999 | 3 | SS | BASILIXIMAB | BASILIXIMAB | 1 | Intravenous (not otherwise specified) | 0 | 20 | MG | QD | ||||||||
116429992 | 11642999 | 4 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
116429992 | 11642999 | 5 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
116429992 | 11642999 | 6 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | 0 | ||||||||||||
116429992 | 11642999 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
116429992 | 11642999 | 8 | C | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
116429992 | 11642999 | 9 | C | DAPSONE. | DAPSONE | 1 | 0 | ||||||||||||
116429992 | 11642999 | 10 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
116429992 | 11642999 | 11 | C | TOCOPHEROL | TOCOPHEROL | 1 | 0 | ||||||||||||
116429992 | 11642999 | 12 | C | EPOETIN ALFA | ERYTHROPOIETIN | 1 | 0 | ||||||||||||
116429992 | 11642999 | 13 | C | VALGANCICLOVIR HYDROCHLORIDE. | VALGANCICLOVIR HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116429992 | 11642999 | 1 | Renal transplant |
116429992 | 11642999 | 2 | Renal transplant |
116429992 | 11642999 | 3 | Renal transplant |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
116429992 | 11642999 | HO |
116429992 | 11642999 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116429992 | 11642999 | Blood bicarbonate decreased | |
116429992 | 11642999 | Mastoiditis | |
116429992 | 11642999 | Otitis externa | |
116429992 | 11642999 | Perichondritis | |
116429992 | 11642999 | Transplant rejection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116429992 | 11642999 | 1 | 20150514 | 0 | ||
116429992 | 11642999 | 2 | 20131122 | 20150519 | 0 | |
116429992 | 11642999 | 3 | 20131122 | 20131126 | 0 |